Fortress Biotech IncFBIO
Price$2.07

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $66.9M+21.3% YoYTTM through 30 Jun 2026
Net Income $111.8MTTM through 30 Jun 2026
Free Cash Flow $125.9MTTM through 30 Jun 2026

Margins

Current
Gross Margin61.2%
EBITDA Margin-42.6%
Operating Margin-48.3%
Net Margin167.3%

Returns

68.0%ROE
30.4%ROA

Balance Sheet Health

Debt / Equity0.19x
Current Ratio2.47x
Net Debt-$216.4Mnet cash position
Cash & Equivalents$196.6M

Quality Metrics

Altman Z-Score-1.71
Piotroski F-Score6 / 9
FCF Margin188.4%
Rule of 40207.8
Earnings-Beat Rate50.0%

Multi-Year Trend

Revenue
'19'20'21'22'23'24'25
FY2025: $63.3M
Diluted EPS$2.77TTM
'21'22'23'24'25
FY2025: $0.24

Dividend

No dividend

Capital Allocation

Capex Intensity0.0%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.